SRDX fiscal fourth-quarter results showcase growth in the medical device segment. The bottom line improves and beats the Zacks Consensus Estimate.
Vous n'êtes pas connecté
TDG's Q4 net sales of $2.19 billion rises 18% from the prior-year level. The reported figure also beats the Zacks Consensus Estimate by 1.1%.
SRDX fiscal fourth-quarter results showcase growth in the medical device segment. The bottom line improves and beats the Zacks Consensus Estimate.
PCG's third-quarter total revenues of $5.94 billion rise 0.9% from the year-ago level. Operating revenues, however, lag the Zacks Consensus Estimate...
AES' third-quarter earnings beat the Zacks Consensus Estimate by 18.3%. However, its revenues miss the consensus estimate by 9.3%.
HII's Q3 revenues of $2.75 billion miss the Zacks Consensus Estimate by 4.5%. The top line also declines 2.4% year over year.
ETR's third-quarter earnings beat the Zacks Consensus Estimate by 2.8%. However, its revenues miss the consensus estimate by 2%.
DUK's third-quarter earnings miss the Zacks Consensus Estimate by 6.4%. Its revenues surpass the consensus estimate by 1.9%.
FOLD's third-quarter 2024 earnings and sales beat the Zacks Consensus Estimate. The company raises its financial guidance for 2024.
CMS' third-quarter 2024 operating revenues totaled $1.74 billion, which lagged the Zacks Consensus Estimate by 4.9%. The top line, however, increased...
LAD's third-quarter earnings beat the Zacks Consensus Estimate while revenues miss the same.
GPI's third-quarter earnings miss the Zacks Consensus Estimate, whereas, revenues beat the same.